Entity Details

Primary name TNR11_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y6Q6
EntryNameTNR11_HUMAN
FullNameTumor necrosis factor receptor superfamily member 11A
TaxID9606
Evidenceevidence at protein level
Length616
SequenceStatuscomplete
DateCreated2001-09-26
DateModified2021-06-02

Ontological Relatives

GenesTNFRSF11A

GO terms

Show/Hide Table
GOName
GO:0001503 ossification
GO:0002250 adaptive immune response
GO:0002548 monocyte chemotaxis
GO:0004888 transmembrane signaling receptor activity
GO:0005031 tumor necrosis factor-activated receptor activity
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0007165 signal transduction
GO:0007267 cell-cell signaling
GO:0008284 positive regulation of cell population proliferation
GO:0009314 response to radiation
GO:0009897 external side of plasma membrane
GO:0016021 integral component of membrane
GO:0019955 cytokine binding
GO:0030316 osteoclast differentiation
GO:0032496 response to lipopolysaccharide
GO:0033209 tumor necrosis factor-mediated signaling pathway
GO:0034097 response to cytokine
GO:0034612 response to tumor necrosis factor
GO:0038023 signaling receptor activity
GO:0043507 positive regulation of JUN kinase activity
GO:0045780 positive regulation of bone resorption
GO:0046872 metal ion binding
GO:0048535 lymph node development
GO:0051091 positive regulation of DNA-binding transcription factor activity
GO:0051092 positive regulation of NF-kappaB transcription factor activity
GO:0060086 circadian temperature homeostasis
GO:0060749 mammary gland alveolus development
GO:0070555 response to interleukin-1
GO:0071812 positive regulation of fever generation by positive regulation of prostaglandin secretion
GO:0071847 TNFSF11-mediated signaling pathway
GO:0071848 positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling
GO:0072674 multinuclear osteoclast differentiation

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001368 TNFR/NGFR cysteine-rich regionDomainDomain
IPR022323 Tumour necrosis factor receptor 11FamilyFamily
IPR022361 Tumour necrosis factor receptor 11AFamilyFamily
IPR034040 Tumor necrosis factor receptor 11A, N-terminalDomainDomain
IPR041648 Rank, cysteine-rich repeat domain 2DomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612301 OMIMOsteopetrosis, autosomal recessive 7 (OPTB7)A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB7 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development. OPTB7 is associated with hypogammaglobulinemia. The disease is caused by variants affecting the gene represented in this entry.
174810 OMIMFamilial expansile osteolysis (FEO)Rare autosomal dominant bone disorder characterized by focal areas of increased bone remodeling. The osteolytic lesions develop usually in the long bones during early adulthood. FEO is often associated with early-onset deafness and loss of dentition. The disease is caused by variants affecting the gene represented in this entry.
602080 OMIMPaget disease of bone 2, early-onset (PDB2)A form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB05959 ENMD-1198Drugbanksmall molecule